Zifo and Maze Therapeutics Partner to Power Precision Medicine
Zifo and Maze Therapeutics have teamed up to launch an AI‑powered platform that manages, stores, and scales massive biobank datasets. The solution tackles the fragmentation of genetic, proteomic, and phenotypic data by providing a unified workflow that delivers summary statistics in under five seconds. Built for scalability, it can incorporate emerging data types such as UKBB‑Proteomics and AGD/NashBio, making the data AI‑ready for downstream drug target discovery. The partnership promises to accelerate target identification and validation across precision‑medicine programs.
Lilly Bests Novo Again, Rare Disease Week Goes Regulatory, More CDC Leadership Upheaval
Eli Lilly’s obesity drug Zepbound achieved a 25.5% weight loss in a head‑to‑head Phase 3 trial, outpacing Novo Nordisk’s CagriSema and sending Novo’s shares down 20%. The FDA launched Rare Disease Week, issuing draft guidance for a new Plausible Mechanism Pathway that...
National Safety Council Launches SIF Prevention Tool that Clinical Laboratories Can Use
The National Safety Council introduced the Organization Safety Gap Analysis Tool, a digital assessment that translates its evidence‑based SIF Prevention Model for clinical laboratories. The ten‑to‑fifteen‑minute, color‑coded questionnaire evaluates seven core safety elements, from leadership to continuous improvement. By highlighting...
SteinCares Forges Licensing Agreement with Shilpa Biologicals for Biosimilars Across Latin America
SteinCares has signed a strategic licensing agreement with Shilpa Biologicals to commercialize a biosimilar across Latin America. Under the deal, SteinCares receives exclusive rights to register, market and distribute the product throughout the region, while Shilpa Biologicals will complete development...
Stryker Unveils Synchfix EVT for Flexible Syndesmotic Ankle Fixation
Medical device maker Stryker has launched Synchfix EVT, a flexible syndesmotic fixation system designed to simplify ankle stabilization procedures. The all‑in‑one, single‑use device integrates suture tensioning handles and a low‑profile titanium medial implant, reducing procedural complexity for both adult and adolescent...
Vico Therapeutics Initiates Patient Dosing for VO659 Phase I/IIa Trial
Vico Therapeutics has initiated patient dosing in an expanded European cohort for its Phase I/IIa VO659 trial, targeting Huntington's disease, spinocerebellar ataxia type 3 and type 1. The study employs a twice‑annual intrathecal regimen and will monitor safety, tolerability, pharmacodynamics and pharmacokinetics...
NorthX Biologics and Demeetra Collaborate on GMP Manufacturing and CLD
NorthX Biologics and Demeetra have formed a strategic alliance to provide an end‑to‑end solution that couples Demeetra’s CleanCut CHO cell line development platform with NorthX’s GMP manufacturing capabilities. The partnership leverages a high‑titre GS‑knockout CHO cell line that carries no...
Evolution Summit By Marcus Evans | May 7-8, 2026 | The Ritz-Carlton, Fort Lauderdale, Florida
The Evolution Summit, organized by Marcus Evans, will take place May 7‑8, 2026 at the Ritz‑Carlton in Fort Lauderdale. The invitation‑only event convenes senior clinical‑trial executives with innovative suppliers to discuss pressing challenges in clinical operations and drug development. Featured speakers include...
Labcorp Expands PathAI Pact to Roll Out Digital Pathology Platform in US
Labcorp announced an expanded partnership with PathAI to deploy the AISight Dx digital pathology platform across its U.S. anatomic pathology labs and hospital sites. The AI‑enabled software will allow pathologists to scan, annotate and diagnose slides digitally, aiming to cut turnaround...
STFC News Release: Hartree Centre and Alder Hey to Tackle NHS Challenges with AI
The Science and Technology Facilities Council’s Hartree Centre has partnered with Alder Hey Children’s NHS Foundation Trust to pilot an AI‑driven staff scheduling platform. The system automatically creates balanced on‑call rotas by factoring in leave, skills and working patterns, replacing...
Five-Year Data Show Sustained Benefits with Briumvi in Relapsing MS
Long‑term data from the Phase 3 ULTIMATE I and II trials show that continuous treatment with Briumvi (ublituximab) provides sustained clinical benefits for relapsing multiple sclerosis over five years. More than 80 % of patients who started Briumvi remained free of relapses and...
Healthcare Platform Gut Clinic Raises $1 Mn in Seed Round
Gut Clinic, a gastro‑metabolic health platform founded in 2024, secured $1 million (≈₹9 crore) in a seed round backed by more than 15 investors. The capital will fund new outpatient centres, upgraded clinical systems, and expanded diagnostic services across India’s $197 billion preventive...
Veg ER for Pets Opens Etobicoke Emergency Hospital as Part of North American Expansion
Veg ER for Pets has opened a 5,000‑sq‑ft, 24/7 veterinary emergency hospital in Etobicoke, marking its first Canadian location and expanding its North American network to 121 facilities. The open‑concept design lets pet owners stay with their animals during treatment, including surgery and...
J&J Reports the FDA’s sBLA Submission for Imaavy to Treat Warm Autoimmune Hemolytic Anemia
Johnson & Johnson has filed a supplemental Biologics License Application (sBLA) with the U.S. FDA for Imaavy (nipocalimab‑aahu), a monoclonal antibody intended to treat warm autoimmune hemolytic anemia (wAIHA). The filing is supported by the Phase II/III ENERGY trial, which demonstrated...
Online Consultations Part of New GP Contract
A new NHS England GP contract, backed by £485 million, will guarantee same‑day appointments for urgent patients. It mandates that online consultation platforms remain available throughout core hours and redirects £292 million to recruit roughly 1,600 additional full‑time‑equivalent GPs. The contract expands...
In Brief SOTU Remarks, Trump Asks Congress to "Codify" MFN
President Donald Trump used a brief four‑minute segment of his State of the Union address to push Congress to codify his Most‑Favoured Nations (MFN) drug‑pricing program. He claimed the voluntary agreements would give Americans the lowest prescription prices worldwide, though...
Opinion: Balancing Safety Access in Rare Disease—Lessons From Sarepta
In July 2025 the FDA ordered a complete halt of Sarepta’s gene‑therapy Elevidys after two non‑ambulatory Duchenne muscular dystrophy (DMD) patients died, sparking a market plunge and patient access concerns. Sarepta argues that ambulatory patients, who had been receiving Elevidys...
Cashing In on ‘Creative Fundamentals’ To Fund Rare Disease R&D
The FDA reauthorized its rare pediatric disease priority review voucher program, bolstering a wave of regulatory incentives that include new guidance on plausible mechanisms and a Rare Disease Evidence Principles framework. Yet ultra‑rare indications still struggle to attract traditional venture...
4 Health Tech Trends Startups Can’t Ignore, Per an Oak HC/FT Partner
Oak HC/FT partner Vig Chandramouli highlighted four health‑tech trends that startups must address to win investor confidence. First, labor management for nurses and allied professionals—who comprise 70% of the workforce—is a largely untapped market. Second, investors are scrutinizing margins, finding...
HFMA CEO Jordan, Healthcare Leaders Point to Urgency of Affordability Challenges During ViVE Conference
At the ViVE health‑tech conference, HFMA CEO Ann Jordan led a panel that warned the industry that healthcare affordability is an urgent, systemic problem. The discussion highlighted the Vitalic Health initiative, which seeks to marry financial sustainability with better outcomes,...
Voice AI in Hearing Care: Improving Access Without Losing the Human Touch
A HIMSS fireside chat highlighted how voice AI is transitioning from pilot projects to production in hearing‑care clinics. PolyAI’s Alex Brown and Audibel’s Brianna Warner discussed using conversational agents to expand patient access while preserving trust and empathy. The session...
The Agentic AI Shift in Healthcare
The HIMSS‑hosted session introduced agentic AI as a transformative operating system for healthcare, capable of ingesting the 99% of hospital data that remains invisible to traditional predictive models. Speakers from Philips, AWS, MIT, and Mass General explained how continuous AI...
NHS Awards Third Digital Deal for £150m Suite of Online Vaccination Services
NHS England has signed a three‑year, £33.6 million contract with London‑based TPXimpact to deliver digital services for maternity and child vaccinations. This agreement is the third digital‑prevention deal signed in the last six months, bringing the total spend on such services...
North York General Smooths ED Flow Using AI
North York General Hospital has become the first Ontario facility to launch SmartER Zones, an AI‑driven system that reallocates patients to less crowded emergency‑department zones. Developed with Signal 1, the algorithm monitors wait times, triage data and zone capacity, then pushes...
Unity Health Achieves High HIMSS Standings
Unity Health Toronto earned Stage 6 validation on both the HIMSS EMRAM and AMAM maturity models, marking the first time all three of its hospitals reached EMRAM Stage 6 and the first North American organization to achieve AMAM Stage 6 under the latest...
Manitoba Introduces ‘Safety App’ for Healthcare
Manitoba's health ministry announced a provincewide rollout of the SAFE mobile app, extending its use from Winnipeg’s Health Sciences Centre to Brandon Regional Health Centre, St. Boniface, Victoria and upcoming sites in Thompson. The app provides emergency notifications, direct security...
Danaher to Buy Masimo in $9.9 Billion Deal in Diagnostics Push
Danaher announced a $9.9 billion acquisition of Masimo, a leader in pulse‑oximetry and AI‑enabled patient‑monitoring devices. The deal places Masimo as a standalone operating company within Danaher’s Diagnostics segment alongside Radiometer, Cepheid and Beckman Coulter. By adding non‑invasive sensor technology, Danaher...
Sioux Lookout Uses Modular Design for First MRI
Sioux Lookout Meno Ya Win Health Centre received two prefabricated modular buildings for its new MRI suite on Feb 18, after a 1,100‑km transport on a 130‑ft super‑load truck. The 1,650‑sq‑ft, magnet‑shielded facility, built off‑site by SDI Canada, is now positioned...
CPhA Drug Database Now Available for Integration
The Canadian Pharmacists Association (CPhA) launched the CPS Content Partner Program, offering API‑based access to its trusted Canadian drug and therapeutic database. The initiative allows EMR vendors, pharmacy management systems, clinical decision support tools, and AI‑enabled health apps to integrate...
UHN’s Medly Now Available Through VITALL
VITALL Intelligence has launched the commercial availability of Medly®, a Health Canada‑approved digital therapeutic for heart failure developed at the University Health Network. The AI‑enhanced smartphone app, already used by more than 3,000 patients, has demonstrated a 50 % reduction in...
MiMedx Group Inc (MDXG) Q4 2025 Earnings Call Transcript
MiMedx Group reported record Q4 2025 results, posting $118 million in net sales—a 27% year‑over‑year increase—and adjusted EBITDA of $29 million, representing 25% of revenue. The company highlighted a strong profit profile with an adjusted gross margin of 86% and GAAP net...
Universal Health Services Inc (UHS) Q4 2025 Earnings Call Transcript
Universal Health Services reported a 10% same‑facility EBITDA increase in Q2 2025, driven by higher acute‑care pricing and a 5.7% rise in net revenue. Adjusted patient days grew, especially in behavioral outpatient services, while cash flow from operations fell $167 million year‑over‑year....
Pebblebrook Hotel Trust (PEB) Q4 2025 Earnings Call Transcript
Brookdale Senior Living reported full‑year 2025 adjusted EBITDA of $458 million, a 19% increase and the fourth straight year of double‑digit growth. Occupancy rose to an 82.5‑83.5% weighted average, the highest level since early 2020, while RevPAR grew 5.7% and adjusted...
Veracyte Inc (VCYT) Q4 2025 Earnings Call Transcript
Veracyte reported fourth‑quarter 2025 revenue of $140.6 million, a 19% year‑over‑year increase driven by strong testing volume and higher average selling prices. Non‑GAAP gross margin rose to 75.1%, with testing margin reaching 76.1% after the transition to the v2 transcriptome platform....
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Transcript
LivaNova reported Q4 2025 revenue of $361 million, a 9.5% constant‑currency increase, and delivered adjusted EPS of $0.86, marking its fifth straight year of double‑digit earnings growth. The cardiopulmonary segment grew 10% year‑over‑year, propelled by ESSENCE heart‑lung machine placements, while epilepsy...
LifeStance Health Group Inc (LFST) Q4 2025 Earnings Call Transcript
LifeStance Health reported 2021 revenue of $668 million, a 77% year‑over‑year increase, and generated $49 million in adjusted EBITDA. The company expanded its clinician base to 4,790, a 55% rise, and now operates in 32 states with over 500 centers. Telehealth accounted...
Dual Regulatory Roles of CPT1C in Chronic Stress-Induced Depression-Related Outcomes
A recent study reveals that carnitine palmitoyltransferase 1C (CPT1C) exerts dual regulatory functions in chronic stress‑induced depression‑related phenotypes. CPT1C enhances surface expression of GluA1‑containing AMPA receptors via SAC1‑mediated lipid signaling while simultaneously dampening mTORC1 activity through AMPK pathways. Genetic deletion...
Amarin Corporation PLC (AMRN) Q4 2025 Earnings Call Transcript
Amarin reported Q4 2024 revenue of $62.3 million, down from a year earlier as U.S. VASCEPA sales fell under generic pressure. Internationally, the company added pricing and reimbursement wins in Europe and grew partnership revenue, boosting total 2024 revenue to $228.6 million....
Agilon Health Inc (AGL) Q4 2025 Earnings Call Transcript
Agilon Health reported FY 2025 revenue of $5.93 billion but posted a negative medical margin of $57 million and an adjusted EBITDA loss of $296 million, with the medical cost trend rising to 6.5% and a $35 million operating expense reduction. Management guided 2026 revenue...
Sarepta Therapeutics Inc (SRPT) Q4 2025 Earnings Call Transcript
Sarepta Therapeutics reported a blockbuster fourth quarter, with ELEVIDYS gene‑therapy sales of $384 million, surpassing guidance by $60 million, and total net product revenue of $1.79 billion for 2024, up 56% year‑over‑year. The company achieved GAAP profitability and cash‑flow positivity, confirming the financial...
Procept Biorobotics Corp (PRCT) Q4 2025 Earnings Call Transcript
Procept Biorobotics reported a 48% year‑over‑year revenue increase to $79.2 million in Q2 2025, driven by strong U.S. growth and a 58% surge in handpiece and consumable sales. Gross margin expanded to 65.4%, up 640 basis points, while adjusted EBITDA loss narrowed...
Pennant Group Inc (PNTG) Q4 2025 Earnings Call Transcript
Pennant Group reported Q2 2025 revenue of $219.5 million, up 30.1% year‑over‑year, and adjusted EBITDA of $16.4 million, up 24.5%. All three operating segments—home health & hospice, senior living, and other services—showed double‑digit growth, with home health/hospice revenue reaching $166 million and senior...
Rxsight Inc (RXST) Q4 2025 Earnings Call Transcript
RxSight reported Q4 2025 revenue of $32.6 million, a 19% year‑over‑year decline driven by sharply lower Light Delivery Device placements. The Light Adjustable Lens accounted for an all‑time high 86% of sales, lifting gross margin to 77.5% despite overall losses. The...
Soleno Therapeutics Inc (SLNO) Q4 2025 Earnings Call Transcript
Soleno Therapeutics reported $190.4 million in net revenue for fiscal 2025, representing less than nine months of commercial sales of its VICAT XR therapy. The company turned profitable, posting $20.9 million net income and generating $48.7 million of operating cash in Q4, ending the...
Teladoc Health Inc (TDOC) Q4 2025 Earnings Call Transcript
Teladoc Health reported Q2 2025 revenue of $631.9 million, a modest 1.6% decline YoY, while adjusted EBITDA reached $69.3 million, hitting the high end of guidance. Integrated care drove growth, delivering $391.5 million in revenue and expanding U.S. membership to 102.4 million, surpassing 100 million members....
US Physical Therapy Inc (USPH) Q4 2025 Earnings Call Transcript
Sensus Healthcare reported Q4 2025 revenue of $4.9 million, a steep decline from $31 million a year earlier, as sales to its former largest customer evaporated. The company highlighted the launch of exclusive CPT codes for its SRT and IGSRT platforms, which...
![[Comment] Fundamental PEPFAR Reform Risks a Period of Structural Vulnerability in the HIV Response](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/70f64a13fa8aff7cafa109f493d87837.webp)
[Comment] Fundamental PEPFAR Reform Risks a Period of Structural Vulnerability in the HIV Response
One year after the 2025 policy upheaval, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) remains without congressional reauthorization, leaving its funding and implementation in flux. The program’s shift toward an “America First” bilateral strategy has re‑engineered coordination mechanisms...
Can VR Be Used for Safe Fall Recovery?
University of Queensland, backed by NIISQ funding, is developing a virtual reality programme to teach fall‑recovery skills to people with spinal cord injury. Building on seven years of research, the project aims to improve confidence, independence and long‑term outcomes by...
Fixing Burnout, Funding and Public Perception in Nursing Homes: AAPACN’s New Blueprint
The American Association of Post‑Acute Care Nursing (AAPACN) unveiled a multi‑year blueprint to tackle nursing‑home workforce burnout, funding volatility, and negative public perception. Its strategy centers on culture change, leadership development, and technology‑driven documentation tools to ease staff burdens. AAPACN...
9 Epic Updates in 30 Days
Epic announced nine significant updates in the past 30 days, ranging from new hospital go‑lives and record‑setting lab data‑exchange deployments to the rollout of its AI Charting tool. Major health systems such as UPMC and Northwell Health are deepening their...